Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma.
about
Immunotherapy for metastatic renal cell carcinomaPodoplanin associates with adverse postoperative prognosis of patients with clear cell renal cell carcinomaCrosstalk between Long Noncoding RNAs and MicroRNAs in Health and DiseasePrognostic Significance of Hypoxia-Inducible Factor Expression in Renal Cell Carcinoma: A PRISMA-compliant Systematic Review and Meta-AnalysisPercutaneous biopsy for risk stratification of renal massesPositive intratumoral chemokine (C-C motif) receptor 8 expression predicts high recurrence risk of post-operation clear-cell renal cell carcinoma patientsImmunotherapy for metastatic renal cell carcinoma.Staging of renal cell carcinoma: Current concepts.Clinico-pathological prognostic factors of renal cell carcinoma: A 15-year review from a single center in GreeceEvaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogramEnhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinomaClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinomaHigh NUCB2 expression level represents an independent negative prognostic factor in Chinese cohorts of non-metastatic clear cell renal cell carcinoma patientsSerum level and immunohistochemical expression of vascular endothelial growth factor for the prediction of postoperative recurrence in renal cell carcinoma.Analysis of lymph node dissection in patients with ≥7-cm renal tumors.Decreasing rates of lymph node dissection during radical nephrectomy for renal cell carcinoma.Pretherapeutic gamma-glutamyltransferase is an independent prognostic factor for patients with renal cell carcinoma.Clinical significance of heparanase splice variant (t5) in renal cell carcinoma: evaluation by a novel t5-specific monoclonal antibodyRUNX3 suppresses migration, invasion and angiogenesis of human renal cell carcinoma.Evaluation of the National Comprehensive Cancer Network and American Urological Association renal cell carcinoma surveillance guidelinesInhibition of angiogenic and non-angiogenic targets by sorafenib in renal cell carcinoma (RCC) in a RCC xenograft modelWhole genome SNP arrays as a potential diagnostic tool for the detection of characteristic chromosomal aberrations in renal epithelial tumors.Prognostic value of preoperative neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios, and multiphasic renal tomography findings in histological subtypes of renal cell carcinoma.p42.3 promotes cell proliferation and invasion in human Renal-Cell Carcinoma.Recent developments in kidney cancerRETRACTED: Management of small renal masses--update 2011.Increased expression of colony stimulating factor-1 is a predictor of poor prognosis in patients with clear-cell renal cell carcinoma.Tumor necrosis on magnetic resonance imaging correlates with aggressive histology and disease progression in clear cell renal cell carcinomaSerum amino acid levels as a biomarker for renal cell carcinoma.Expression of IL-4 and IL-13 predicts recurrence and survival in localized clear-cell renal cell carcinoma.Clinical and prognostic factors for renal parenchymal, pelvis, and ureter cancers in SEER registries: collaborative stage data collection system, version 2The relationship between the preoperative systemic inflammatory response and cancer-specific survival in patients undergoing potentially curative resection for renal clear cell cancerLong-term survival rates after resection for locally advanced kidney cancer: Memorial Sloan Kettering Cancer Center 1989 to 2012 experience.Expression of CIP2A in renal cell carcinomas correlates with tumour invasion, metastasis and patients' survival.High expression of interleukin-11 is an independent indicator of poor prognosis in clear-cell renal cell carcinomaTumor miR-125b predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection.Molecular classification of renal tumors by gene expression profiling.Serum 20S proteasome is elevated in patients with renal cell carcinoma and associated with poor prognosis.Prognostic significance of ST3GAL-1 expression in patients with clear cell renal cell carcinomaVaccination immunotherapy--an update.
P2860
Q24186688-784AA4AF-D1C1-4552-8DFE-3D6CEBAEFEB7Q26743903-6C644117-757F-41CD-AD27-34EF5272F619Q26765464-77252124-012A-4DD6-9CAE-B857CFFEC54FQ26781470-120D397F-54F8-4BBA-89B6-0DF8D4C62799Q26783525-83E48AAC-4714-4705-991B-4414042F15DAQ28602010-11BB0DDB-9E65-4DAC-AAE0-20D3133C535EQ30234458-88A505FC-6C46-4F86-87AF-9A4805606C47Q33599726-F8B98A1F-AB18-41B2-901E-22120E80C700Q33614217-BC9DC908-8463-4ADD-8E9F-123B342748CDQ33627815-F3A571D9-1A1A-4716-8C5B-BC7B160BFC48Q33710169-50FF78AA-CB73-455A-8BA2-1B0B2D391ADEQ33758217-B86F508C-D050-4D6C-AFCC-B2CDB8724282Q33798805-EA5F570B-52D1-49F1-B672-58E0AF5F7D1BQ33811628-1808969F-8C6A-400B-965B-91593B4F5B9AQ34028672-F243B64F-3AE2-4BD4-8649-F8D2040BA6D3Q34270351-290BA84E-9569-4CF0-AFDD-FE018BA46513Q34354554-EE435093-2A21-4EBC-9368-6692BA73BE68Q34516760-53F8A2C8-EF8B-49DE-B630-7DCF1DCCE1CAQ34606632-C7BE170D-AD7F-4FD3-8FC7-1A29324ED1AFQ34692256-6CAB8DD1-027D-4F4B-BA3F-0BFBDB2564A1Q34727359-11C168EF-917A-46A3-9DBB-55416248A154Q34745214-454FE75C-95AD-4603-A0F9-71A0472DD126Q34793982-5153FB13-BE59-4611-A1D7-0A6F37B19DB6Q35017015-15CD8426-3A43-4138-9AD8-9CDF46FAC3DFQ35042440-C89CA912-D1B6-4926-9E1F-E029D93588AAQ35071185-7C59A5CD-CC64-404D-B829-EB8F7C8FDF83Q35118187-F8F5641A-5598-4608-B2C6-B89E5C9E42B4Q35190220-9B0CE1A7-8F52-404F-B621-94B4B42DAA96Q35234267-2226C51C-5509-4D5C-8B57-5D2A1F83A9BDQ35405080-B67F6312-987B-46C4-B695-E88922737FD4Q35439990-3BBB148A-4FA7-4639-815A-3FA0FE2934ABQ35551037-CDDEC881-AB13-4CA1-9794-806D66895697Q35630107-CE70BA4A-AE73-46F4-94BD-3203BEFF06F1Q35653981-B0B2E417-9D5B-405E-947B-199933648A10Q35674197-A12544E4-3DBA-47D0-B8C2-8FF442EC1DD3Q35713525-26ABC5FB-8C0A-444B-ACB0-76644F530730Q35789932-5759FB14-3ACC-447A-A101-B53804DC9709Q35835132-A3C93C35-9E19-4814-9136-9C8A7CD555EBQ35836524-8DCDE7A4-87D7-4417-96D7-5CCE72E74E62Q35851700-748FB90B-A27B-4879-81E6-91BC16B2606C
P2860
Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Risk group assessment and clin ...... resected renal cell carcinoma.
@ast
Risk group assessment and clin ...... resected renal cell carcinoma.
@en
type
label
Risk group assessment and clin ...... resected renal cell carcinoma.
@ast
Risk group assessment and clin ...... resected renal cell carcinoma.
@en
prefLabel
Risk group assessment and clin ...... resected renal cell carcinoma.
@ast
Risk group assessment and clin ...... resected renal cell carcinoma.
@en
P2093
P356
P1476
Risk group assessment and clin ...... resected renal cell carcinoma.
@en
P2093
Allan J Pantuck
Amnon Zisman
Arie S Belldegrun
Debby H Chao
Fredrick Dorey
Jean B deKernion
Jeffery Wieder
Jonathan W Said
Robert A Figlin
P304
P356
10.1200/JCO.2002.05.111
P407
P577
2002-12-01T00:00:00Z